AJANTPHARM2021-01-012021-03-31in-bse-fin:OneOperatingExpenses01Member AJANTPHARM2021-01-012021-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AJANTPHARM 2020-04-01 2021-03-31 2021-04-21 INR Crores Yearly true Cash Flow Indirect Single segment Pharmaceutical 2021-01-01 2021-03-31 Audited Standalone 7480700000.00 13300000.00 7494000000.00 1715300000.00 224500000.00 77800000.00 1334400000.00 21800000.00 294800000.00 1657900000.00 5326500000.00 2167500000.00 0.00 2167500000.00 685500000.00 -65800000.00 619700000.00 0.00 1547800000.00 0.00 0.00 0.00 0.00 1547800000.00 4800000.00 1552600000.00 1552600000.00 0.00 173900000.00 2 17.89 17.89 0.00 0.00 17.89 17.89 1. The above standalone results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 30 April 2021. The Statutory Auditors have expressed unmodified opinion. the audit report ha been filled with the stock exchange and is available on company webiste. 2. The figures for the quarter ended 31 March 2021 and 31 March 2020 are the balancing figures between audited figures in resoect of full financial year and the unaudited published year to date figure upto the third quarter ended 31 December 2020 and 31 December 2019. 4. During the Year 5,500 equity shares (previous year 7,500l) of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Employees Stock Options Scheme, 2011, resulting in an increase in the paid-up share capital by Rs. 11,000 (previous year Rs. 15,000) and securities premium by Rs. 0.58 crores (previous year Rs. 0.93 croresl). 5. Exceptional item in the quarter and year ended 31 March 2020 represents loss due to a fire and other events at Guwahati plant net of insurance claim. 6. During the year, Company had bought back its 7,35,000 equity shares, being 0.84% of the total paid up equity share capital at Rs. 1,850 per equity share for an aggregate amount of Rs. 135.98 crores and extinguished those shares on 30 December 2020. 7. The Company continued to take into account the possible impacts of COVID-19 in preparation of the financial statements, including but not limited to its assessment of liquidity and going concern assumption, recoverable values of its financial and non-financial assets, impact on revenues and on costs. The Company has been able to effectively manage the operations till now with appropriate safety precautions, without any significant impact of COVID-19 on the business. The Company will continue to closely monitor future economic conditions to ensure business continuity. 10. The group Operates execlusively in one reportable buiness segment i.e Pharmaceuticals . 11. The Financial Results are available for investors at on the Company's Website www.ajantapharma.com, www.nseindia.comand www.bseindia.com Single segment 2020-04-01 2021-03-31 Audited Standalone 27185900000.00 1035700000.00 28221600000.00 7040900000.00 1005900000.00 -746000000.00 4981100000.00 69000000.00 1114900000.00 5734900000.00 19200700000.00 9020900000.00 0.00 9020900000.00 2166800000.00 97700000.00 2264500000.00 0.00 6756400000.00 0.00 0.00 0.00 0.00 6756400000.00 -13300000.00 6743100000.00 6743100000.00 0.00 173900000.00 2 28675900000.00 77.59 77.59 0.00 0.00 77.59 77.59 Other Expenses 1657900000.00 Other Expenses 5734900000.00 69000000.00 -1980300000.00 -594800000.00 0.00 -363200000.00 6200000.00 -7800000.00 13200000.00 0.00 119000000.00 0.00 119200000.00 -3300000.00 1114900000.00 108900000.00 12200000.00 22800000.00 -93700000.00 7900000.00 47000000.00 832100000.00 19700000.00 0.00 -117500000.00 0.00 0.00 0.00 200000.00 0.00 -2371900000.00 6649000000.00 0.00 0.00 0.00 1979100000.00 0.00 4669900000.00 0.00 0.00 6782200000.00 7424100000.00 0.00 0.00 0.00 0.00 0.00 1669700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 832100000.00 19700000.00 0.00 -167000000.00 0.00 -1626800000.00 0.00 0.00 0.00 0.00 0.00 1359800000.00 0.00 0.00 0.00 0.00 132300000.00 0.00 829000000.00 43700000.00 316400000.00 -7800000.00 -2689000000.00 354100000.00 0.00 354100000.00 849500000.00 1203600000.00